ニュース一覧

米国のニュース（2017年1月）

1月31日（火）
● カネカ・コエンザイムQ10
The Federal Circuit Court of Appeals Renders Decision in favor of Kaneka Corporation in the Appeal in the U.S. Patent Infringement Lawsuit Related to Coenzyme Q10
● 東芝・インテレクチュアル・ベンチャーズ
Toshiba Didn’t Infringe Intellectual Ventures IP, Jury Says
● 電源制御チップ
On Appeal, Infringement Ruling Gets the Jitters
● マイラン・テバ・多発性硬化症治療薬Copaxone（グラチラマー酢酸塩）
Mylan wins US District Court ruling related to Copaxone patents
● リアルダ (メサラジン)
Mylan enjoined from bringing Lialda generic to market
● アプタリス・アポテックス・骨格筋弛緩剤Amrix（シクロベンザプリン）
Aptalis Pharamtech, Inc. v. Apotex Inc.
● バイオシミラー
Supreme Court to Consider BPCIA Requirements for Biosimilars


1月30日（月）
● カンバーランド製薬・アセタドーテ（アセチルシステイン）
U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case
● 抗PCSK9抗体 Amgen v. Regeneron
Is the PCSK9 patent fight giving Amgen's Repatha a boost? Script numbers say so


1月28日（土）
● 携帯電話のカメラ
Huawei Reaches Deal To Settle E-Watch Phone Patent Suit
● クアルコム
Trump told to stop gov’t lawsuit over Qualcomm patent licensing
● TCハートランド v. クラフトフーズ
TC Heartland v. Kraft Foods: Will the Court Curb Patent-Law Forum Shopping?
● クレームドラフティング
Patent Strategy: Advanced Patent Claim Drafting for Inventors
● 統合失調症薬・Fanapt (イロペリドン)
Roxane Labs., Inc. v. Vanda Pharms., Inc.
● リアルダ (メサラジン)
Shire Prevails In Patent Trial Over Mylan's Generic Lialda
● Ematic錠
Anton Innovations allege Ematic tablets infringe patents


1月27日（金）
● 半導体デバイス・ビデオゲーム
Judge Keeps OmniVision Patent Suit in Del., Eschews Calif.
● アップル v. Ameranth
Federal Circuit Invalidates Ameranth’s Menu Software Patents as Unpatentable Abstract Ideas
● 刑務所の電話システム
Prior Deal Gives Telecom Win In Prison Phone Patent Suit
● ビーコンナビゲーション v. フォード・モーター
Beacon Navigation GmbH v. Ford Motor Company
● eコマース
Boca Office Furniture accused of patent infringement
● エネルギー産業
Intellectual property in the energy sector
● バーコードスキャン
Honeywell announces patent suit against Code Corp. over barcode scanners
● ペメトレキセド・リリー v. テバ
Federal Circuit Finds Infringement Under Akami Of Two-Step Method Of Treatment


1月26日（木）
● 携帯電話のカメラ
ZTE Reaches Settlement In E-Watch Phone Patent Fight
● アップル v. クアルコム
Apple continues antitrust fight with Qualcomm with two new lawsuits


1月24日（火）
● インクカートリッジ
How Lexmark's patent fight to crush an ink reseller will affect us all
● ボトルキャップ
Validity of bottle cap patent upheld in IPR thanks to market success in Peru
● アップル v. クアルコム
Qualcomm could slap Apple with a lawsuit of its own
● 特許適格性
USPTO Publishes Business Method Subject Matter Eligibility Examples: Part II
● パテントチャレンジ
Patent Challengers Must Show Harm to Appeal Final PTAB Decisions
● ジェネリック薬・Pay-for-Delay
Endo Settles FTC "Pay-for-Delay" Charges
● ペメトレキセド・リリー v. テバ
Federal Circuit Finds Infringement Under Akamai Of Two-Step Method Of Treatment


1月23日（月）
● BMW
BMW sues car company in counterfeit suit
● アップル v. クアルコム
Apple Lawsuit Could Undermine Qualcomm’s Royalty Business, Analyst Says
● バーコードスキャン
Honeywell sues for patent infringement
● グラフィックスプロセッサ
Qualcomm, Sony, LG targeted by Section 337 complaint over patents practiced by Intel processors
● フィターゼ
U.S. Water Wins Appeal in Patent Infringement Case Against Novozymes in U.S. Court of Appeals for the Federal Circuit
● オプジーボ・キートルーダ・小野薬 v. メルク
BMS, Ono, Merck settle Keytruda patent suit
● アムジェン v. サンド
Biosimilars: Supreme Court Grants Certiorari in Amgen v. Sandoz


1月22日（日）
● アップル v. クアルコム
Apple's Full lawsuit against Qualcomm Comes to Light Revealing Secret Licensing Agreements and more


1月21日（土）
● オプジーボ・キートルーダ・小野薬 v. メルク
Merck to pay $625 million plus royalties on Keytruda sales through 2026 under patent deal
● アップル v. クアルコム
Apple files $1 billion lawsuit against chip supplier Qualcomm
● 電子取引・特許適格性
Commodity Trading System and Method are Patent Eligible Subject Matter Under 101
● 分子診断
Where do we go from here? The evolving landscape of molecular diagnostics
● 医薬ライフサイクルマネジメント
How Drug Life-Cycle Management Patent Strategies May Impact Formulary Management
● ライフサイエンス・方法特許
Life sciences patents: method claims – united they stand, divided do they fall?


1月20日（金）
● バーコードスキャン
Honeywell Files Lawsuit Against Code Corporation Claiming Widespread Patent Infringement
● QRコード
QR code lawsuit aimed at Bath & Body Works for patent infringement
● グラフィックスプロセッサ
ITC investigates huge patent complaint
● クアルコム・反トラスト法
FTC Lawsuit Charges Qualcomm With Antitrust Violations
● 2016年第4四半期
Litigation Roundup: Fourth Quarter 2016
● ミシェル・リー長官
Michelle Lee to Stay on as USPTO Director
● バイオテクノロジー
Inherent Anticipation for Biotechnology Inventions
● ペメトレキセド・リリー v. テバ
Teva Liable for Induced Infringement of Eli Lilly’s Lung Cancer Drug ALIMTA
● バイオシミラー・パテントダンス
Supreme Court Will Judge Biosimilar Patent Dance


1月19日（木）
● 電子取引・特許適格性
CAFC finds graphical user interface patent claims eligible, CBM decision still pending
● LTE技術
WiLAN gets day in court w/ Ericsson for patent infringement
● グラフィックスプロセッサ
U.S. begins patent probe of graphics processors, DDR memory controllers
● クアルコム
FTC’s Qualcomm Suit Exposes Tensions in Smartphone Industry
● DPP-4阻害剤・特許適格性
District Court Broadens Scope of Patent Ineligibility Under § 101 for a Treatment Method
● オメプラゾール製剤
Apotex’s Infringement of AstraZeneca’s Omeprazole Formulation Patent Upheld
● ペメトレキセド・リリー v. テバ
Instructions Induced Prescribing Physicians to Infringe
● ANDA
Copying As Objective Evidence Of Non-Obviousness In ANDA Cases Is Alive And Well
● バイオシミラー
Supreme Court to Consider Biologics Price Competition and Innovation Act


1月18日（水）
● クアルコム・反トラスト
U.S. antitrust agency sues Qualcomm over patent licensing
● ウェブサイト
Heineken faces website patent infringement claims
● ソフトウェア
Effective Advocacy for Software Patents
● コンタクトレンズ
U.S. Supreme Court declines to hear J&J contact lens patent dispute
● コパクソン（酢酸グラチラマー注射液）・テバ・マイラン
Teva sues Mylan over Copaxone patent infringement
● ペメトレキセド・リリー v. テバ
Federal Circuit Provides Guidance on Divided Infringement, Inducement of Infringement, and Indefiniteness
● Tecfidera (フマル酸ジメチル)・バイオジェン+フォワードファーマ
Biogen to Pay $1.25B to Settle Patent Lawsuit (BIIB)
● アムジェン v. サンド
Supreme Court to Review BPCIA -- Amgen v. Sandoz Petitions for Writs of Certiorari Granted


1月17日（火）
● 監視システム・Digital Ally v. Utility Associates
Digital Ally Wins Major Legal Victory as the United States Court of Appeals for the Federal Circuit Affirms the Invalidity of Key Claims in Utility Associates' '556 Patent
● NFLのストリーミング
Kudelski's OpenTV Files Patent Suit Against NFL Enterprises
● Seatoun Media v. アップル
Apple’s iMessages Sued For Infringing Point-of-Sale Patent
● アップル v. サムスン
United States Court of Appeals Re-opens Apple v. Samsung Design Suit
● 2016年・訴訟減少
Patent, Copyright Lawsuit Volumes Fall in 2016
● バイオジェン+フォワード・ファーマ
Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug
● 180日独占期間・バイオシミラー
US Supreme Court to decide on me-too drug waiting period
● Amgen v. Sandoz
Breaking News: Supreme Court Grants Petition and Cross-Petition for Certiorari in Amgen v. Sandoz
● 抗PCSK9抗体 Amgen v. Regeneron
Amgen v. Regeneron: Will the permanent injunction against Regeneron’s new PCSK9-inhibitor hold up on appeal?


1月16日（月）
● Seatoun Media v. アップル
A New Patent Troll Lawsuit Claims that Apple's 'Messages' App Infringes their Acquired Patent from Voice Express
● ソニー v. 富士フイルム
Sony files patent infringement suit against Fujifilm in S.D. Fla. over magnetic tape media
● バイオシミラー
Novartis takes biosimilar delay complaint to Supreme Court


1月14日（土）
● IBM・1位
This company won the most patents in 2016 (more than Google, Amazon and Apple combined)
● ハイブリッドカー
Abell Foundation and Paice settle patent case with Volkswagen
● アップル v. サムスン
Apple vs. Samsung Lawsuit Over iPhone Design Officially Reopened
● Webセキュリティ
Zscaler Tells Customers Not to Worry About Symantec IP Lawsuit
● 2017年・注目
IP Cases to Watch in 2017
● 多発性硬化症・Aubagio（teriflunomide）
Mylan sued for patent infringement over Aubagio
● ドラッグデリバリー
MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI)
● バイオシミラー・パテントダンス
US Supreme Court to Review Biosimilar ‘Patent Dance’
● アリムタ
US Court of appeals rules in Lilly's favour on Alimta vitamin regimen patent


1月13日（金）
● スナップチャット・電子メッセージ
Snapchat Sued Over Electronic Messaging Patents
● カーナビ
Beacon Navigation GmbH v. Ford Motor Company
● アップル・ノキア
Apple, Nokia in a spat over Patent Licensing
● マルウェア対策機能
Google Anti-Malware Technology Patent Case Set For Trial
● スマートフォン
Supreme Court ruling throws Apple's $400M patent win into question, could impact other design patent litigation
● パテントトロール
The joy of patents, part 3: Patent trolls degrade innovation
● アリムタ・抗がん剤
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
● 抗PCSK9抗体 Praluent (alirocumab)
Sanofi confident it can overturn Praluent patent ruling
● 180日独占期間・ジェネリック
180-Day Exclusivity for Generics: FDA Releases Draft Guidance


1月12日（木）
● シスコ v. アリスタ
Cisco v. Arista patent and copyright infringement cases see conflicting rulings at ITC, N.D. Cal.
● 電子商取引
Kate Hudson's Fabletics Fires Back at Alleged Patent Troll
● 特許適格性
Gust、Inc. v。Alphacap Ventures、LLC（SDNY 2016）。O2 Media、LLC対Narrative Science Inc.（ND Ill。2017）
● 抗PCSK9抗体Praluent (alirocumab)・Repatha (evolocumab)
Sanofi and Regeneron’s appeal to suspend Amgen injunction denied
● アリムタ・抗がん剤
Teva 'Disappointed' In Court's Patent Decision
● Ampyra・多発性硬化症薬
Supreme Court Declines to Revisit Broad Personal Jurisdiction Over ANDA Filers
● コンパニオン診断
Strong Intellectual Property Strategy in Companion Diagnostics Creates Growth Opportunities
● 遺伝子配列
Judge in gene-sequencing lawsuit blocks Illumina's claim against Cornell


1月11日（水）
● QRコード
Bath & Body Works alleged to have infringed patents with QR codes in advertisements
● CHR暗号モジュール
Pantaurus alleges CHR cryptographic module infringes patent
● マルウェア対策機能
Malware patent suit against Google advances toward trial
● パイス+フォルクスワーゲン・アウディ・ポルシェ
Paice Settles Dispute with VW, Audi and Porsche Relating to Hybrid Vehicle Patents
● 点眼薬・ジフルプレドナート
PTAB's Decision on Obviousness of Eye Drop Patent
● ImmunoGen・カドサイラ・抗がん剤
Phigenix, Inc. v. ImmunoGen, Inc. (Fed. Cir. 2016)
● バイオシミラー
Goodwin Publishes Biosimilars Patent Litigation Update, Biosimilars Investment Guidelines


1月10日（火）
● Apple-Nokia訴訟
Will Apple Survive Nokia’s New Patent Lawsuit?
● 自動データ処理システム
Fabletics fights back in dispute with ‘patent troll’
● ブーツ
Ugg Australia's Parent Company Files Patent, Trade Dress Suit Against H&M
● 医療機器
Farmington Hills firm represents well-known medical device company in patent infringement case
● アムジェン・PCSK9訴訟
Amgen Statement on January 9, 2017, U.S. District Court Decision
● バイエル・避妊薬
Supreme Court will not hear patent dispute over Bayer contraceptives
● カドサイラ・抗がん剤
Federal Circuit dismisses Phigenix patent appeal in ImmunoGen case
● ジェネリック医薬品
Supreme Court will not hear case over drug patent lawsuit venue
● 2017年・注目ケース
IP Cases to Watch at the Supreme Court in 2017